Richard W. Mott, Director at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 181,978 shares at $22.92 ($4.2M) on 2023-01-30, disclosed to the SEC on 2023-01-30.
Open-market sale of $4.2M TMCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.92 | 61,528 | $1.4M | 33.3% |
| 2 | $22.92 | 61,528 | $1.4M | 33.3% |
| 3 | $23.87 | 27,422 | $655K | 15.5% |
| 4 | $23.87 | 27,422 | $655K | 15.5% |
| 5 | $24.58 | 2,039 | $50K | 1.2% |
| 6 | $24.58 | 2,039 |
| $50K |
| 1.2% |
| Total | $23.24 avg | 181,978 | $4.2M | 100% |
| Filing → |
| TMCI | BUY | 2024-05-13 | $1.1M | — | Filing → |
| TMCI | SELL | 2023-04-10 | $105K | — | Filing → |
| TMCI | SELL | 2023-04-05 | $415K | — | Filing → |